RDY Book Value Per Share from 2010 to 2025

RDY Stock

USD 13.27 0.02 0.15%

Dr Reddys Book Value Per Share yearly trend continues to be fairly stable with very little volatility. Book Value Per Share is likely to outpace its year average in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Dr Reddys Laboratories according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

1.5 K

Current Value

1.6 K

Quarterly Volatility

958.20579495

Credit Downgrade

Yuan Drop

Covid

Check Dr Reddys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dr Reddys' main balance sheet or income statement drivers, such as Interest Expense of 2.1 B, Total Revenue of 337.1 B or Gross Profit of 197.6 B, as well as many indicators such as Price To Sales Ratio of 0.7, Dividend Yield of 0.0271 or PTB Ratio of 0.86. RDY financial statements analysis is a perfect complement when working with Dr Reddys Valuation or Volatility modules.

Check out the analysis of Dr Reddys Correlation against competitors.

Latest Dr Reddys' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Dr Reddys Laboratories over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Dr Reddys' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dr Reddys' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 381.36 X

10 Years Trend

Pretty Stable

Compare to Others All Fundamentals

Book Value Per Share

Timeline

RDY Book Value Per Share Regression Statistics

	Arithmetic Mean	1,145
	Geometric Mean	828.47
	Coefficient Of Variation	83.72
	Mean Deviation	597.88
	Median	935.02
	Standard Deviation	958.21
	Sample Variance	918,158
	Range	4.3K
	R-Value	0.17
	Mean Square Error	955,509
	R-Squared	0.03
	Significance	0.53
	Slope	34.10
	Total Sum of Squares	13.8M

RDY Book Value Per Share History

	2025	1592.18
	2024	1516.36
	2023	1684.85
	2022	1402.48
	2021	1148.56
	2020	1055.09
	2019	935.02

Other Fundumenentals of Dr Reddys Laboratories

Tangible Book Value Per Share

Dr Reddys Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Retained Earnings	Accounts Payable	Long Term Debt	Short Term Investments	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Net Receivables	Good Will	Total Current Assets	Treasury Stock	Short Term Debt	Net Tangible Assets	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Capital Surpluse	Cash And Equivalents	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.98	0.1	0.97	-0.15	0.93	0.97	0.89	0.95	-0.06	-0.04	0.93	0.98	0.98	1.0	-0.06	0.93	0.07	-0.04	0.13	-0.18	-0.16	0.17	0.14	0.12	0.16
Total Stockholder Equity	0.98		0.29	0.91	-0.16	0.97	0.89	0.86	0.87	0.1	0.07	0.84	0.93	0.91	0.99	-0.23	0.83	0.22	0.08	0.01	-0.21	-0.1	0.19	0.31	0.29	0.3
Retained Earnings	0.1	0.29		-0.11	0.05	0.35	-0.15	0.07	-0.2	0.84	0.58	-0.24	-0.04	-0.11	0.13	-0.83	-0.26	0.69	0.63	-0.55	-0.06	0.33	0.04	0.83	0.85	0.7
Accounts Payable	0.97	0.91	-0.11		-0.13	0.85	1.0	0.9	0.99	-0.22	-0.15	0.97	0.99	0.99	0.96	0.11	0.97	-0.03	-0.15	0.24	-0.14	-0.22	0.15	0.0	-0.02	0.0
Long Term Debt	-0.15	-0.16	0.05	-0.13		-0.24	-0.13	0.18	-0.16	0.38	0.07	-0.06	-0.18	-0.15	-0.19	0.12	-0.16	-0.01	0.19	-0.21	0.99	0.44	-0.49	-0.13	-0.13	-0.07
Short Term Investments	0.93	0.97	0.35	0.85	-0.24		0.83	0.74	0.81	0.07	-0.01	0.76	0.88	0.85	0.95	-0.22	0.76	0.2	-0.03	-0.08	-0.3	-0.12	0.37	0.39	0.37	0.38
Total Liab	0.97	0.89	-0.15	1.0	-0.13	0.83		0.89	1.0	-0.25	-0.16	0.98	0.99	0.99	0.95	0.15	0.99	-0.08	-0.16	0.26	-0.14	-0.23	0.12	-0.07	-0.09	-0.04
Intangible Assets	0.89	0.86	0.07	0.9	0.18	0.74	0.89		0.85	0.11	0.04	0.88	0.89	0.88	0.86	-0.01	0.85	0.11	0.16	0.14	0.17	-0.02	-0.07	0.07	0.07	0.04
Common Stock	0.95	0.87	-0.2	0.99	-0.16	0.81	1.0	0.85		-0.31	-0.21	0.98	0.97	0.99	0.94	0.2	0.99	-0.14	-0.23	0.29	-0.16	-0.26	0.14	-0.13	-0.15	-0.06
Property Plant Equipment	-0.06	0.1	0.84	-0.22	0.38	0.07	-0.25	0.11	-0.31		0.64	-0.3	-0.17	-0.22	-0.06	-0.71	-0.33	0.71	0.76	-0.51	0.33	0.67	-0.24	0.59	0.62	0.45
Current Deferred Revenue	-0.04	0.07	0.58	-0.15	0.07	-0.01	-0.16	0.04	-0.21	0.64		-0.22	-0.06	-0.13	-0.03	-0.81	-0.23	0.62	0.74	-0.42	0.08	0.34	-0.58	0.38	0.46	0.07
Net Debt	0.93	0.84	-0.24	0.97	-0.06	0.76	0.98	0.88	0.98	-0.3	-0.22		0.94	0.97	0.91	0.23	0.98	-0.17	-0.19	0.37	-0.06	-0.3	0.07	-0.18	-0.19	-0.09
Net Receivables	0.98	0.93	-0.04	0.99	-0.18	0.88	0.99	0.89	0.97	-0.17	-0.06	0.94		0.98	0.97	0.03	0.95	0.04	-0.1	0.17	-0.19	-0.19	0.14	0.07	0.06	0.03
Good Will	0.98	0.91	-0.11	0.99	-0.15	0.85	0.99	0.88	0.99	-0.22	-0.13	0.97	0.98		0.96	0.11	0.98	-0.07	-0.15	0.24	-0.15	-0.21	0.13	-0.06	-0.08	-0.01
Total Current Assets	1.0	0.99	0.13	0.96	-0.19	0.95	0.95	0.86	0.94	-0.06	-0.03	0.91	0.97	0.96		-0.09	0.91	0.1	-0.04	0.11	-0.23	-0.18	0.2	0.18	0.16	0.19
Treasury Stock	-0.06	-0.23	-0.83	0.11	0.12	-0.22	0.15	-0.01	0.2	-0.71	-0.81	0.23	0.03	0.11	-0.09		0.26	-0.84	-0.76	0.39	0.18	-0.25	0.19	-0.76	-0.81	-0.42
Short Term Debt	0.93	0.83	-0.26	0.97	-0.16	0.76	0.99	0.85	0.99	-0.33	-0.23	0.98	0.95	0.98	0.91	0.26		-0.21	-0.22	0.34	-0.15	-0.26	0.13	-0.2	-0.23	-0.11
Net Tangible Assets	0.07	0.22	0.69	-0.03	-0.01	0.2	-0.08	0.11	-0.14	0.71	0.62	-0.17	0.04	-0.07	0.1	-0.84	-0.21		0.68	-0.22	-0.07	0.41	-0.16	0.76	0.8	0.41
Long Term Investments	-0.04	0.08	0.63	-0.15	0.19	-0.03	-0.16	0.16	-0.23	0.76	0.74	-0.19	-0.1	-0.15	-0.04	-0.76	-0.22	0.68		-0.08	0.16	0.27	-0.36	0.51	0.53	0.25
Short Long Term Debt	0.13	0.01	-0.55	0.24	-0.21	-0.08	0.26	0.14	0.29	-0.51	-0.42	0.37	0.17	0.24	0.11	0.39	0.34	-0.22	-0.08		-0.18	-0.56	0.03	-0.39	-0.43	-0.27
Long Term Debt Total	-0.18	-0.21	-0.06	-0.14	0.99	-0.3	-0.14	0.17	-0.16	0.33	0.08	-0.06	-0.19	-0.15	-0.23	0.18	-0.15	-0.07	0.16	-0.18		0.45	-0.53	-0.25	-0.24	-0.2
Capital Surpluse	-0.16	-0.1	0.33	-0.22	0.44	-0.12	-0.23	-0.02	-0.26	0.67	0.34	-0.3	-0.19	-0.21	-0.18	-0.25	-0.26	0.41	0.27	-0.56	0.45		-0.26	0.1	0.13	0.03
Cash And Equivalents	0.17	0.19	0.04	0.15	-0.49	0.37	0.12	-0.07	0.14	-0.24	-0.58	0.07	0.14	0.13	0.2	0.19	0.13	-0.16	-0.36	0.03	-0.53	-0.26		0.26	0.2	0.26
Net Invested Capital	0.14	0.31	0.83	0.0	-0.13	0.39	-0.07	0.07	-0.13	0.59	0.38	-0.18	0.07	-0.06	0.18	-0.76	-0.2	0.76	0.51	-0.39	-0.25	0.1	0.26		0.98	0.72
Net Working Capital	0.12	0.29	0.85	-0.02	-0.13	0.37	-0.09	0.07	-0.15	0.62	0.46	-0.19	0.06	-0.08	0.16	-0.81	-0.23	0.8	0.53	-0.43	-0.24	0.13	0.2	0.98		0.65
Capital Stock	0.16	0.3	0.7	0.0	-0.07	0.38	-0.04	0.04	-0.06	0.45	0.07	-0.09	0.03	-0.01	0.19	-0.42	-0.11	0.41	0.25	-0.27	-0.2	0.03	0.26	0.72	0.65

Click cells to compare fundamentals

About Dr Reddys Financial Statements

Dr Reddys investors use historical fundamental indicators, such as Dr Reddys' Book Value Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dr Reddys. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	1.5 K	1.6 K
Tangible Book Value Per Share	1.3 K	1.4 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for RDY Stock Analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC